Beijing, China

Enyun Shen

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Enyun Shen: Innovator in Cancer Diagnostics

Introduction

Enyun Shen is a prominent inventor based in Beijing, China, known for his significant contributions to the field of cancer diagnostics. With a total of six patents to his name, Shen has focused on developing innovative solutions for diagnosing epithelium-derived cancers.

Latest Patents

One of Shen's latest patents is titled "Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof." This invention provides uses of cytokeratins as markers for diagnosing epithelium-derived cancers. It includes cancer-related epitopes of cytokeratins and monoclonal antibodies that specifically recognize these epitopes. The invention also outlines methods for early screening, diagnosis, or prognosis of epithelium-derived cancers in subjects, as well as methods for evaluating the therapeutic effect of related medicaments or therapies, and kits for accomplishing these methods. Another notable patent is "HER3 antibodies and uses thereof," which describes antibodies specific for HER3 and methods of treating cancer in subjects by administering an effective amount of these antibodies.

Career Highlights

Shen has worked with notable companies such as Beijing Cotimes Biotech Co. Ltd. and Beijing Cotimes Biotech Ltd. His work in these organizations has contributed to advancements in biotechnology and cancer treatment.

Collaborations

Shen has collaborated with talented individuals in his field, including Yang Song and Shiqi Ren. Their combined expertise has furthered the development of innovative cancer diagnostic methods.

Conclusion

Enyun Shen's work in cancer diagnostics exemplifies the impact of innovation in medical science. His patents and collaborations highlight his commitment to improving cancer detection and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…